- Joanna Coast (jo.coast@bristol.ac.uk), senior lecturer in health economics1
- 1 Department of Social Medicine, University of Bristol, Bristol BS8 2PR
- Accepted 16 September 2004
Introduction
The technical expertise required for conducting economic evaluations and interpreting their results continues to increase. Current best practice includes cost effectiveness acceptability curves, net-benefit frameworks, and probabilistic modelling.1 These methods are valuable, but by generating a pseudoscientific aura around economic evaluation, they camouflage critical weaknesses in current techniques. In this article, I describe the evolution of economic evaluation in health care (see box for terminology), explore the assumptions underlying current approaches and the resulting concerns, and suggest an alternative approach.
Why do we need economic evaluation?
People who are not economists often find it difficult to understand the importance of the theory behind the comparison of costs and effects. After all, if we compare two washing machines of equal cost and one works for 10 years and the other for 15, it is clear that the machine lasting 15 years is a better buy. The need for theory arises, however, because interpersonal rather than within individual comparisons are involved; in health care the question is not, generally, whether I choose the 10 or 15 year washing machine but whether I get the 10 year washing machine or you get the one lasting 15 years.
Welfare economics
Economic evaluation stems from Paretian welfare economics. It incorporates the principles that individuals are the best judges of their own wellbeing and that, if one person can be made better off without another being made worse off, there is global improvement in welfare. This value judgment is uncontroversial but, in policy terms, practically useless: few policies benefit some individuals without affecting others.
Terminology used in economic evaluation
Cost benefit analysis—Costs valued in money and compared with outcomes also valued in money
Cost effectiveness analysis—Costs …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: How much of a social media profile can doctors have?
Published 13 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 13 February 2012
Re: Is it unethical for doctors to encourage healthy adults to donate a kidney to a stranger? No
Published 13 February 2012
Re: Report predicts 20 million AIDS orphans in Africa by 2010
Published 13 February 2012
Re: On the impossibility of being expert
Published 13 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012